17-28758496-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001077498.3(FAM222B):āc.1463C>Gā(p.Ala488Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001077498.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM222B | NM_001077498.3 | c.1463C>G | p.Ala488Gly | missense_variant | 3/3 | ENST00000581407.6 | NP_001070966.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM222B | ENST00000581407.6 | c.1463C>G | p.Ala488Gly | missense_variant | 3/3 | 1 | NM_001077498.3 | ENSP00000462419.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000405 AC: 1AN: 246908Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134070
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460078Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726350
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2024 | The c.1463C>G (p.A488G) alteration is located in exon 4 (coding exon 2) of the FAM222B gene. This alteration results from a C to G substitution at nucleotide position 1463, causing the alanine (A) at amino acid position 488 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at